Dodge & Cox 13F: Cuts Elanco Animal Health (ELAN) Stake by $251M
Dodge & Cox reduced its stake in Elanco Animal Health by over 10 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Dodge & Cox sold 10,140,205 shares from its stake in Elanco Animal Health Incorporated ($ELAN), a 12.82% decrease, according to a 13F filing with the SEC dated May 14, 2026. It reported 68,944,100 shares worth $1.71 billion at the end of the quarter.
Since the filing, $ELAN is down 1.5% after 1 week, up 12.2% after 1 month and up 8.8% to date (from the $21.64 close on May 14, 2026).
ELAN
Elanco Animal Health Incorporated
Key Points
- Dodge & Cox cut its position in Elanco Animal Health by 10,140,205 shares, reducing its stake by 12.8% to 68,944,100 shares.
- Elanco Animal Health's stock recently traded around $23.04, with a market cap of approximately $12 billion and a 52-week range of $13.16 to $27.72.
- The filing reflects Dodge & Cox's holdings as of the reporting period and may not represent its current position.
Get $ELAN trade alerts by text
We text you when insiders, Congress or big funds trade $ELAN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Elanco Animal Health Incorporated alert may contain errors. Disclosures
Dodge & Cox has reduced its stake in Elanco Animal Health Incorporated (ELAN), according to its latest Form 13F filing with the SEC. The investment firm cut its holdings by 10,140,205 shares, a 12.8% decrease, leaving it with 68,944,100 shares valued at about $1.59 billion. This change reflects the firm's position as of the reporting period and may not indicate its current stance.
What Changed in Dodge & Cox's Elanco Position
Dodge & Cox trimmed its investment in Elanco Animal Health by over 10 million shares, bringing its total holdings to approximately 68.9 million shares. This reduction represents a 12.8% decrease from its previous position of 79,084,305 shares, with the shares now valued at roughly $1.59 billion.
Elanco Animal Health Incorporated Stock Up 9.7%
Shares of Elanco Animal Health were trading around $23.04 recently. The company boasts a market capitalization of about $12 billion. It has experienced a 52-week low of $13.16 and a high of $27.72. The stock's beta is 1.696, indicating more volatility compared to the broader market. Elanco is not currently profitable, reflected in its negative EPS of -0.5.
About Elanco Animal Health
Elanco Animal Health Incorporated, based in Indianapolis, Indiana, is a global player in the animal health industry. The company develops and markets products for both pets and farm animals, including parasiticides, vaccines, and therapeutics. Elanco's offerings help in protecting pets from parasites and treating various health conditions. For farm animals, the company provides products aimed at improving health and wellbeing, supporting livestock production. Founded in 1954, Elanco employs around 9,400 people under the leadership of CEO Jeffrey N. Simmons.
Bottom Line
Dodge & Cox's recent reduction in Elanco Animal Health shares is a notable move in its portfolio management. While the filing provides a snapshot of the firm's holdings during the reporting period, it may not reflect any changes made since then. Investors often track such filings for insights into institutional investment trends and strategies.
Related Filing Alerts
Source: Dodge & Cox's 13F filing on $ELAN (May 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Dodge & Cox 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts